|
Biotechnology
News Network:
Medicine Today
Topic:
Technology
The Guardian:
Thousands take to streets in Sao Paulo and Rio de Janeiro to denounce Iranian president's record on rights and IsraelProtests greeted Mahmoud Ahmadinejad in Brazil at the start of a South American tour intended to bolster the (Read More)
SF Gate:
Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study. The company said the drug candidate DR Cysteamine met tolerability and dosin (Read More)
News Networks:
Innovation,
Firehose,
One Of The Intersections Of Race, Politics, Feminism And Hip Hop
...
Topic:
Business
Wall Street Journal:
BOSTON (MarketWatch) -- Drug stocks advanced substantially in early action Monday, echoing gains in the broader market, while shares of Cephalon Inc. fell on news that a later-stage clinical study for its pediatric drug Cinq (Read More)
SeekingAlpha.com: Home Page:
Techne Corporation (TECH) is a mid-cap biotechnology company that offers a good risk/reward profile, It is engaged in the development and manufacture of biotechnology products and hematology calibrators and controls. The comp (Read More)
News Networks:
1 Random Thought,
Current Business News
www.guardian.co.uk:
Governments at the world summit on food security at the headquarters of the UN Food and Agriculture Organisation in Rome last week took few of the required steps to respond to rising hunger (World leaders agree to global foo (Read More)
SeekingAlpha.com: Home Page:
Tom Lydon (ETF Trends) submits: The biotechnology sector is once again finding its footing, with some ETFs focused on the sector up more than 30% since the market’s March 9 low. But there have been stumbling blocks on the wa (Read More)
News Network:
Current Business News
www.guardian.co.uk:
Problem of biodiversity loss has been 'eased off centre stage' by focus on climate change, according to Prof Edward Wilson, the ecologist described as 'Darwin's natural heir'The diversity of life on Earth is undergoing an "im (Read More)
Wall Street Journal:
BOSTON (MarketWatch) -- Drug stocks clung to the flat line early Friday as shares of Poniard Pharmaceuticals slid for the second day. The NYSE Arca Pharmaceutical Index was down marginally at 301.14 while the NYSE Arca Biot (Read More)
ETF Trends:
The biotechnology sector is once again finding its footing, with some exchange traded funds (ETFs) focused on the sector up more than 30% since the market’s March 9 low. But there have been stumbling blocks on the way back to (Read More)
News Network:
Current Business News
Topic:
Technology
Pune-Cities-The Times of India:
A seven-member team of the University of Pune's five-year integrated M.Sc biotechnology course won a bronze medal at the annual iGEM competition at the MIT. (Read More)
Health News from Medical News Today:
The Biotechnology Industry Organization (BIO) announces that Presidents Bill Clinton and George W. Bush, the 42nd and 43rd Presidents of the United States, will appear together for a moderated discussion at the 2010 BIO Inter (Read More)
News Network:
The Proteomics News Network
Topic:
Biotech
SF Gate:
Ligand Pharmaceuticals Inc. said Thursday it received a $2 million milestone payment from Merck & Co. as part of a research collaboration. The company said the partnership covers a range of research programs. It is due to exp (Read More)
The Economist:
Toyota spent the most on research and development (R&D) of any company in the world in 2008, according to the European Commission’s latest tally. The Japanese carmaker increased its annual R&D spending by 7.6% to €7.6 billion (Read More)
Wall Street Journal:
BOSTON (MarketWatch) -- Allergan Inc. and Medicis Pharmaceutical Corp. led drug stocks lower early Thursday as shares of the dermatology-products makers fell on news that a new bill unveiled by Senate Democrats would levy a (Read More)
SF Gate:
Delcath Systems Inc., a developer of a cancer-drug delivery device, said Wednesday it raised $32.4 million in net proceeds from a public stock offering. The figure is above the $30.6 million that the New York-based company ha (Read More)
timesofindia.indiatimes.com:
The selection process for appointing faculty members for Anna University's prestigious Centre for Biotechnology in Chennai is mired in a controversy following allegations of favouritism. (Read More)
News Network:
Current Business News
Add something
|
|
|
|
|
